Long-term Safety Study of BHV-7000 in Participants With Major Depressive Disorder (MDD)

PHASE2Enrolling by invitationINTERVENTIONAL
Enrollment

480

Participants

Timeline

Start Date

August 1, 2024

Primary Completion Date

November 30, 2027

Study Completion Date

November 30, 2027

Conditions
Major Depressive Disorder
Interventions
DRUG

BHV-7000

BHV-7000 75 mg taken once daily

Trial Locations (66)

10029

Berman Clinical, New York

Icahn School of Medicine at Mount Sinai, New York

10128

The Medical Research Network, LLC, New York

10329

RBA, Staten Island

10549

Bioscience Research LLC, Mount Kisco

11235

SPRI Clinical Trials, LLC, Brooklyn

11516

Neurobehavioral Research, Inc, Cedarhurst

18104

Lehigh Center for Clinical Research, Allentown

18509

Scranton Medical Institute, Moosic

19063

Suburban Research Associates, Media

20877

CBH Health, Gaithersburg

21208

Headlands Pharmasite, Baltimore

29405

Coastal Carolina Research Center, North Charleston

30030

CenExel iResearch, LLC, Decatur

31405

CenExel iResearch, LLC, Savannah

32256

Clinical Neuroscience Solutions, Inc, Jacksonville

32801

Clinical Neuroscience Solutions, Inc., Orlando

33016

Floridian Neuroscience Institute, Miami Lakes

33407

Neuroscience Research Institute, West Palm Beach

33607

K2 Medical Research, Tampa

39232

Precise Clinical Research, Flowood

45417

Midwest Clinical Research Center, Dayton

60123

Revive Research Institute, Inc., Elgin

60640

Uptown Research Institute, Chicago

63141

Arch Clinical Trials, St Louis

66210

Collective Medical Research, Overland Park

70115

DelRicht Research, New Orleans

72204

Pillar Clinical Research, LLC, Little Rock

72211

WIRG, Little Rock

72758

WRN, Rogers

75093

Aim Trials, Plano

75115

InSite Clinical Research, LLC, DeSoto

75234

FutureSearch Trials of Dallas, Dallas

75243

Relaro Medical Trials, LLC, Dallas

76309

Grayline Research Center, Wichita Falls

77373

Red Oak Psychiatry Associates, PA, Houston

78737

Donald J. Garcia, MD, PA dba Austin Clinical Trial Partners, Austin

80910

MCB Clinical Research Centers, Colorado Springs

84015

Alpine Reseach Organization, Clinton

85012

IMA Clinical Research, Phoenix

85226

Reverie Mind, LLC, Chandler

89102

IMA Clinical Research, Las Vegas

90025

CalNeuro Research Group, Los Angeles

90504

Cenexel CNS, Torrance

90706

CIT LA, Bellflower

91316

WR-PRI Encino, Encino

91710

IPMG, Chino

91786

Pacific Clinical Research Management Group, Upland

92056

Excell Research, Inc., Oceanside

92374

Anderson Clinical Research, Redlands

92506

CIT IE, Riverside

92805

Advanced Research Center, Inc., Anaheim

92845

Collaborative Neuroscience Research, LLC (CenExel - CNS), Garden Grove

92868

NRC Research Institute, Orange

94305

Stanford, Stanford

94596

Sunwise Clinical Research, Walnut Creek

95124

Lumos Clinical Research Center, LLC, San Jose

97210

Summit Headlands LLC, Portland

98007

Northwest Clinical Research Center, Bellevue

06030

UConn Health, Farmington

06360

Optum Behavioral Care of Connecticut, PC dba Comprehensive Psychiatric Care of Connecticut, Norwich

02116

Copley Clinical, Boston

02131

Boston Clinical Trials, Boston

02472

Adams Clinical, Watertown

08002

Center for Emotional Fitness, Cherry Hill

08755

Bio Behavioral Health, Toms River

Sponsors
All Listed Sponsors
lead

Biohaven Therapeutics Ltd.

INDUSTRY

NCT06423781 - Long-term Safety Study of BHV-7000 in Participants With Major Depressive Disorder (MDD) | Biotech Hunter | Biotech Hunter